ADGRG2 and congenital bilateral aplasia of vas deferens from CFTR mutation: In recent decades, with the advent of next-generation sequencing, several of these candidate genes such as ADGRG2 (Patat et al., 2016) and copy number variants (CNVs) in SLC9A3 (Wang et al., 2017) have been validated in some CAVD patients.